Prolactin and β-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 45, Issue 11, 1996, Pages 1434-1440

  Kinsley, Brendan T ^a   Levy, Carol J ^a   Simonson, Donald C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; PROLACTIN;

ADAPTATION; ADRENALIN RELEASE; ADULT; ARTICLE; BLOOD BRAIN BARRIER; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE;

EID: 0029800715     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90127-4     Document Type: Article

References (61)

1. White NH, Skor DA, Cryer PE, et al: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
2. Simonson DC, Tamborlane WV, DeFronzo RA, et al: Intensive insulin therapy reduces the counterregulatory hormone responses to hypoglycemia in patients with type 1 diabetes. Ann Intern Med 103:184-190, 1985
3. Amiel SA, Tamborlane WV, Simonson DC, et al: Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
4. Bolli GB, De Feo P, De Cosmo S, et al: A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus. Diabetes 33:732-737, 1984
5. Heller SR, Herbert M, MacDonald IA, et al: Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet 2:359-363, 1987
6. Amiel SA, Sherwin RS, Simonson DC, et al: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
7. Lingenfelser T, Renn W, Sommerwerck U, et al: Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin induced hypoglycemia in IDDM patients. Diabetes 42:610-618, 1993
8. Kinsley BT, Simonson DC: Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:684-691, 1996
9. Kinsley BT, Widom B, Simonson DC: Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM: Effect of glycemic control. Diabetes Care 18:17-26, 1995
10. Widom B, Simonson DC: Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41:1597-1602, 1992
11. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
12. Davis MR, Shamoon H: Counterregulatory adaptation to hypoglycemia in normal humans. J Clin Endocrinol Metab 73: 995-1001, 1991
13. Veneman T, Mitrakou A, Mokan M, et al: Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42:1233-1237, 1993
14. Davis MR, Mellman M, Shamoon H: Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 41:1335-1340, 1992
15. McCall AL, Fixman LB, Fleming N, et al: Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251: E442-E447, 1986
16. Pelligrino DA, Segil LJ, Albrecht RF: Brain glucose utilization and transport and cortical function in chronic vs acute hypoglycemia. Am J Physiol 259:E729-E735, 1990
17. Boyle PJ, Nagy RJ, O'Connor A, et al: Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 91:9352-9356, 1994
18. Boyle PJ, Kempers SF, O'Connor AM, et al: Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333:1726-1732, 1995
19. Hirsch BR, Shamoon H: Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes 36:20-26, 1987
20. Kinsley BT, Widom B, Utzschneider K, et al: Stimulus specificity of defects in counterregulatory hormone secretion in insulin dependent diabetes mellitus: Effect of glycemic control. J Clin Endocrinol Metab 79:1383-1389, 1994
21. Rattarasarn C, Dagogo-Jack S, Zachwiega JJ, et al: Hypoglycemia induced autonomie failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 43:809-818, 1994
22. Mokan M, Mitrakou M, Veneman T, et al: Hypoglycemia unawareness in IDDM. Diabetes Care 17:1397-1403, 1994
23. Hepburn DA, Patrick AW, Brash HM, et al: Hypoglycemia unawareness in type 1 diabetes: A lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabetic Med 8:934-945, 1991
24. Clarke WL, Gonder-Fredrick LA, Richards LE, et al: Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes 40:680-685, 1991
25. Dagogo-Jack S, Craft S, Cryer P: Hypoglycemia-associated autonomic failure in insulin dependent diabetes. J Clin Invest 91:819-828, 1993
26. Guansing AR, Leung Y, Ajlouni K, et al: The effect of hypoglycemia on TSH release in man. J Clin Endocrinol Metab 40:755-758, 1975
27. Bing-You RG, Spratt DI: Serum estradiol but not gonadotropin levels decrease acutely after insulin-induced hypoglycemia in cycling women. J Clin Endocrinol Metab 75:1054-1059, 1992
28. Frier BM, Fisher BM, Gray CE, et al: Counterregulatory hormonal responses to hypoglycemia in type 1 (insulin dependent) diabetes: Evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia 31:421-429, 1988
29. Iranmanesh A, Lizarralde G, Veldhuis JD: Coordinate activation of corticotrophic axis by insulin-induced hypoglycemia: Simultaneous estimates of beta-endorphin, adrenocorticotropin and cortisol secretion and disappearance in normal men. Acta Endocrinol (Copenh) 128:521-528, 1993
30. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomie neuropathy. Br Med J 285:916-918, 1982
31. McGuire EA, Helderman JH, Tobin JD, et al: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
32. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
33. Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technique. Diabetes 14:771-779, 1965
34. Boyle PJ, Schwartz NS, Shah SD, et al: Plasma glucose at the onset of hypoglycemia in patients with poorly controlled diabetes and in non-diabetics. N Engl J Med 318:1487-1492, 1988
35. Fanelli CG, Epifano L, Rambotti AM, et al: Meticulous prevention of hypoglycemia normalizes the glycaemic thresholds and magnitude of most neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
36. Fanelli C, Pampanelli S, Epifano L, et al: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia following institution of rational intensive insulin therapy in IDDM. Diabetologia 34:1265-1276, 1994
37. Cranston I, Lomas J, Maran A, et al: Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287, 1994
38. Davis M, Mellman M, Friedman S, et al: Recovery of epinephrine response but not hypoglycaemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med 97:535-541, 1994
39. Lingenfelser T, Buettner U, Martin J, et al: Improvement of impaired counterregulatory hormone response and symptom perception by short-term avoidance of hypoglycemia in IDDM. Diabetes Care 18:321-325, 1995
40. Dagogo-Jack S, Rattarasarn C, Cryer PE: Reversal of hypoglycaemic unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
41. Copinschi G, L'Hermite M, Leclerque R, et al: Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. J Clin Endocrinol Metab 40: 442-449, 1975
42. Woolf PD, Lee LA, Leebaw W, et al: Intracellular glycopenia causes prolactin release in man. J Clin Endocrinol Metab 45:377-383, 1977
43. Fisher BM, Hepburn DA, Frier BM, et al: Pancreatic and pituitary hormonal responses to insulin induced hypoglycemia during muscarinic cholinergic blockade in man. Eur J Clin Invest 22:614-618, 1992
44. Iranmanesh A, Veldhuis JD, Carlsen EC: Attenuated pulsatile release of prolactin in men with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 71:73-78, 1990
45. Djursing H, Carstensen L, Hagen C: Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM). Acta Endocrinol (Copenh) 107:450-455, 1984
46. Moriarty KT, Simpson EJ, Brown NS, et al: Effect of acute mild hypoglycemia on counterregulatory responses to moderate hypoglycemia induced immediately afterwards in healthy men. Clin Sci 85:537-542, 1993
47. Nakao K, Nakai Y, Jingami H, et al: Substantial rise of plasma beta-endorphin levels after insulin induced hypoglycemia in human subjects. J Clin Endocrinol Metab 49:838-841, 1979
48. Evans PJ, Dieguez C, Rees LH, et al: The effect of cholinergic blockade on the ACTH, beta-endorphin and cortisol responses to insulin induced hypoglycemia. Clin Endocrinol (Oxf) 24:687-691, 1986
49. Iranmanesh A, Lizarralde G, Veldhuis JD: Coordinate activation of the corticotropic axis by insulin-induced hypoglycemia: Simultaneous estimates of beta-endorphin, adrenocorticotropin and cortisol secretion and disappearance in normal men. Acta Endocrinol (Copenh) 128:521-528, 1993
50. Radosevich PM, Lacy DB, Brown LL, et al: Effect of insulin induced hypoglycemia on plasma and cerebrospinal fluid levels of ir-beta-endorphin, ACTH, cortisol, norepinephrine, insulin and glucose in the conscious dog. Brain Res 458:325-338, 1988
51. Serri O, Rasio E, Somma M: Effects of naloxone on insulin induced release of pituitary hormones. J Clin Endocrinol Metab 53:206-208, 1981
52. Bright GM, Kaiser DL, Rogol AD, et al: Naloxone attenuates recovery from insulin induced hypoglycemia in normal man. J Clin Endocrinol Metab 57:213-216, 1983
53. Van Loon G, Alel N: β-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res 204:236-241, 1981
54. Ipp E, Garberoglio C, Richter H, et al: Naloxone decreases centrally induced hyperglycemia in dogs. Diabetes 33:619-621, 1984
55. Suda T, Sato Y, Sumitomo T, et al: Beta-endorphin inhibits hypoglycemia induced gene expression of corticotropin-releasing factor in the rat hypothalamus. Endocrinology 130:1325-1330, 1992
56. Nash JA, Radosevich PM, Lacy DB, et al: Effects of naloxone on glucose homeostasis during insulin induced hypoglycemia. Am J Physiol 257:E367-E373, 1989
57. El-Tayeb KMA, Brubaker PL, Lickley HLA: Effect of opiate receptor blockade on normoglycemic and hypoglycemic glucoregulation. Am J Physiol 250:E326-E342, 1986
58. Wanke T, Lahrmann H, Auinger M, et al: Endogenous opioid system during inspiratory loading in patients with type 1 diabetes. Am Rev Respir Dis 148:1335-1340, 1993
59. Caprio S, Gerety G, Tamborlane WV, et al: Opiate blockade enhances hypoglycaemic counterregulation in normal and insulin dependent diabetic subjects. Am J Physiol 260:E852-E858, 1991
60. Pardridge WM, Boado RJ, Farrell CR: Brain-type glucose transporter (GLUT 1) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization. J Biol Chem 265:18035-18040, 1990
61. Kumagai AK, Kang YS, Boado RJ, et al: Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44:1399-1404, 1995